126 completed, 26 unknown, 19 recruiting, 13 terminated. 200 Phase 2, 27 Phase 3, 18 Phase 1.
Follow Atorvastatin: new trials by email Literature Review of Atorvastatin trials Research Report on Atorvastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period. Allogeneic umbilical cord mesenchymal stem cell, Aspirin Enteric-coated Tablets & Atorvastatin Calcium - Cerebral Infarction | Phase 1 / Phase 2 | Suspended | Sclnow Biotechnology Co., Ltd. | 40 | 2026-12-31 | 2026-04-23 |
| Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO) Atorvastatin - Graves Disease, Graves Disease (Basedow's Disease) | Phase 2 | Not yet recruiting | Region Skane | 554 | 2026-11-01 | 2026-10-20 |
| Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin Standard of Care + atorvastatin, Standard of Care (SOC) - Ovarian Cancer, Fallopian Tube Cancers | Phase 2 | Not yet recruiting | University of Colorado, Denver | 40 | 2026-09-01 | 2026-09-11 |
| Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease Atorvastatin and Lisinopril, Placebo - Chest Wall Tumor, Breast Cancer | Phase 2 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 60 | 2026-08-12 | 2026-09-17 |
| A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID Maraviroc (MVC), Atorvastatin, 10mg, 20mg, 40mg, Placebo, Maraviroc - Long COVID | Phase 2 / Phase 3 | Not yet recruiting | HealthBio, Inc. | 252 | 2026-07-15 | 2026-06-18 |
| PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC Axitinib, Toripalimab, Atorvastatin - Advanced Renal Cell Carcinoma (RCC), PTC | Phase 1 / Phase 2 | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 40 | 2026-05-14 | 2026-06-05 |
| Prospective Management of Plaque Instability With Statins and Extra Folic Acid Atorvastatin plus folic acid, Atorvastatin - Carotid Atherosclerotic Plaque | Phase 1 / Phase 2 | Recruiting | Ruijin Hospital | 180 | 2026-03-01 | 2026-07-02 |
| ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) Atorvastatin 20 mg, Atorvastatin 40 mg, Atorvastatin 60 mg - Pulmonary Tuberculosis (TB) | Phase 2 | Recruiting | Obafemi Awolowo University Teaching Hospital | 80 | 2026-01-03 | 2026-01-23 |
| Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis Atorvastatin 20 mg, Placebo - Decompensated Liver Cirrhosis, Cirrhosis | Phase 2 | Recruiting | CAMC Health System | 50 | 2025-09-09 | 2026-02-25 |
| Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis statin + ezetimibe, Statin monotherapy (rosuvastatin or atorvastatin) - Ischemic Stroke, Hypercholesteremia | Phase 2 | Recruiting | Chang Gung Memorial Hospital | 300 | 2025-08-01 | 2025-12-30 |
| Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH) Atorvastatin 80 mg/day, Placebo atorvastatin - Arrhythmogenic Cardiomyopathy | Phase 2 | Recruiting | Centro Cardiologico Monzino | 102 | 2025-03-31 | 2026-10-26 |
| A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer Letrozole, Letrozole and atorvastatin, Fulvestrant - Breast Cancer | Phase 2 | Completed | Lund University Hospital | 126 | 2025-01-02 | 2025-09-10 |
| High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI Statin monotherapy (rosuvastatin or atorvastatin), Placebo - ST Elevation (STEMI) Myocardial Infarction | Phase 2 | Active not recruiting | Sheikh Zayed Federal Postgraduate Medical Institute | 66 | 2024-12-02 | 2025-04-11 |
| Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke PCSK9 inhibitors combined with atorvastatin/rosuvastatin, Atorvastatin/Rosuvastatin - Acute Ischemic Stroke | Phase 2 / Phase 3 | Completed | Xiang Luo | 429 | 2024-11-29 | 2026-06-09 |
| Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet Atorvastatin 10mg, Modification of dietary fat composition - Epilepsy, Dyslipidemia | Phase 1 / Phase 2 | Enrolling by invitation | Johns Hopkins University | 22 | 2024-10-04 | 2026-10-19 |
| Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma Atorvastatin, Placebo Administration, Computed Tomography - Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIA Cutaneous Melanoma AJCC v8 | Phase 2 | Active not recruiting | OHSU Knight Cancer Institute | 150 | 2024-09-01 | 2026-03-13 |
| Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy Statin - Solid Tumors, Ototoxicity | Phase 1 / Phase 2 | Completed | Minia University | 56 | 2024-09-01 | 2026-01-20 |
| Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury Atorvastatin Calcium, Minocycline Hydrochloride, Candesartan Cilexetil - Traumatic Brain Injury | Phase 2 | Enrolling by invitation | University of California, San Francisco | 672 | 2024-08-01 | 2025-12-22 |
| Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer Placebo, Atorvastatin - Hearing Loss, Head and Neck Cancer | Phase 2 | Recruiting | National Institute on Deafness and Other Communication Disorders (NIDCD) | 224 | 2024-07-10 | 2026-09-02 |
| Prophylactic Treatment With Atorvastatin for Episodic Migraine. Atorvastatin 40mg, Placebo, Atorvastatin 20mg - Episodic Migraine | Phase 2 | Recruiting | St. Olavs Hospital | 450 | 2024-05-01 | 2026-07-14 |
Showing 20 of 200. Sign in to see all of them.
Hypercholesterolemia (22) · Dyslipidemias (16) · Hyperlipidemias (15) · Breast Neoplasms (12) · Cardiovascular Diseases (8) · Diabetes Mellitus (7) · Metabolic Syndrome (5) · Myocardial Infarction (5) · Prostatic Neoplasms (5) · Tuberculosis (5) · Cardiotoxicity (4) · Chronic Periodontitis (4) · Inflammation (4) · Ischemic Stroke (4) · Stroke (4)
Tanta University (5) · Aegerion Pharmaceuticals, Inc. (4) · Eli Lilly and Company (4) · Government Dental College and Research Institute, Bangalore (4) · M.D. Anderson Cancer Center (4) · University Health Network, Toronto (4) · Esperion Therapeutics, Inc. (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Obafemi Awolowo University Teaching Hospital (3) · Peking University People's Hospital (3) · Sanofi (3) · AstraZeneca (2) · Chang Gung Memorial Hospital (2) · Chinese Academy of Medical Sciences, Fuwai Hospital (2) · Damanhour University (2)
United States (89) · China (19) · Canada (13) · Egypt (11) · Denmark (8) · Italy (8) · Taiwan (6) · Mexico (5) · United Kingdom (5) · Netherlands (4) · Sweden (4) · Australia (3) · Brazil (3) · France (3) · India (3)
Bolanle A Omotoso, MD (3) · Amira B Kassem, PhD (2) · Chivers Woodruff, Jr, MD (2) · Cynthia Strout, MD (2) · Dennis McCluskey, MD (2) · Frank H Christensen, MD (2) · Harry Geisberg, MD (2) · James Zavoral, MD (2) · Jeff Geohas, MD (2) · Linda Murray, MD (2) · Linn H Steffensen, Associate Professor II (2) · Marco Mielcarek (2)
PMID 38018702, PMID 30183102, PMID 25060413, PMID 25660356, PMID 26872608, PMID 11877368, PMID 15207950, PMID 15883262, PMID 17118406, PMID 17384435, PMID 19073787, PMID 19201496, PMID 19208914, PMID 19421322, PMID 19929989, PMID 19932542, PMID 20003436, PMID 20110022, PMID 20204386, PMID 20339006, PMID 20863951, PMID 20923537, PMID 21067804, PMID 21144505, PMID 21166928, PMID 21310077, PMID 21473764, PMID 21518985, PMID 21752880, PMID 21958521, PMID 22089718, PMID 22117606, PMID 22140269, PMID 22169113, PMID 22175654, PMID 22209480, PMID 22264573, PMID 22362846, PMID 22459680, PMID 22463922, PMID 22606998, PMID 23040716, PMID 23113833, PMID 23482473, PMID 24256611, PMID 25047021, PMID 25095746, PMID 25103444, PMID 25175924, PMID 25771069
P30CA015704 (2), 2004 (1), 2005 (1), 2016 (1), 2023 (1), K23AG026752 (1), K23GM101463 (1), N01CN35000 (1), P01CA018029 (1), P30CA015083 (1), P30CA060553 (1), R01HL065176 (1), R01HL075771 (1), R01HL108307 (1), R01HL111659 (1)